PAKCILLINE

This brand name is authorized in Nigeria.

Active ingredients

The drug PAKCILLINE contains one active pharmaceutical ingredient (API):

1
UNII 7C782967RD - AMPICILLIN
 

Ampicillin is a broad spectrum penicillin, indicated for the treatment of a wide range of bacterial infections caused by ampicillin sensitive organisms.
 
Read more about Ampicillin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A11-100420 Capsule Pakcilline Capsules CAP 250 mg 10 X 10 Pakcilline Capsules A11-100420 Pakcilline AMPICILLIN ANTIBIOTICS AMPICILLIN 250MG CAPSULES 10 X 10 PRESCRIPTION ONLY MEDICINE TREATMENT OF SUSCEPTIBLE BACTERIA INFECTIONS CHARLES MEKUS PHARMACEUTICAL & STORES NIG. LTD NIGERIA CHARLES MEKUS PHARMACEUTICAL & STORES NIG. LTD NIGERIA 08/25/2022 08/24/2027 25/08/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J01CA01 Ampicillin J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CA Penicillins with extended spectrum
Discover more medicines within J01CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A11-100420

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈